tiprankstipranks
Enlivex Therapeutics Ltd (ENLV)
NASDAQ:ENLV
US Market
ENLV
Enlivex
RESEARCH TOOLSreports

Enlivex (ENLV) Income Statement

515 Followers

Enlivex Income Statement

Last quarter (Q4 2025), Enlivex's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Enlivex's net income was $1.24B. See Enlivex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -332.00K$ -545.00K$ -835.00K$ -777.00K$ -546.00K
Operating Expenses
$ 14.67M$ 14.99M$ 29.39M$ 25.80M$ 19.29M
Depreciation and Amortization
$ 332.00K$ 545.00K$ 835.00K$ 777.00K$ 546.00K
EBITDA
$ -14.67M$ -14.47M$ -28.22M$ -25.02M$ -18.74M
Operating Income
$ -15.00M$ -15.54M$ -29.39M$ -25.80M$ -19.29M
Other Income/Expenses
$ 1.63B$ 522.00K$ 327.00K$ -5.26M$ 4.82M
Pretax Income
$ 1.62B$ -15.01M$ -29.07M$ -31.06M$ -14.47M
Net Income
$ 1.24B$ -15.01M$ -29.07M$ -31.06M$ -14.47M
Per Share Metrics
Basic EPS
$ 27.04$ -0.73$ -1.56$ -2.31$ -0.54
Diluted EPS
$ 25.48$ -0.73$ -1.56$ -2.31$ -0.54
Weighted Average Shares Outstanding
 45.70M 20.51M 18.57M 18.39M 17.86M
Weighted Average Shares Outstanding (Diluted)
 48.50M 20.51M 18.57M 18.39M 17.86M
Currency in USD

Enlivex Earnings and Revenue History